• Overview & Objectives
  • Credit Eligibility
  • Funding Support
May 22, 29 & June 5, 2024
7:00 - 9:00 pm EDT
6.0 Mainpro+ Credits
Virtual (free)
View Agenda



This program will cover the latest topics in cardiovascular and metabolic disease, guidelines, late-breaking clinical trial results and address patient care issues encountered in daily practice.

Learning Objectives

Following participation in this program, participants will be able to:

Session 1

  • Describe challenges with anticoagulation in patients with comorbidities
  • Identify how to appropriately diagnose and manage MINOCA (Myocardial Ischemia without obstructive CAD
  • Select the appropriate treatment for the management of CKD
  • Examine the clinical decisions for the selection of Finerenone to treat CKD

Session 2

  • Describe appropriate management strategies for heart failure
  • Recognize the importance of lipid-related risk reduction
  • Consider the role of PCSK9 inhibitors and colchicine for patients following an MI
  • Determine the role of Lp(a) for cardiovascular risk stratification

Session 3

  • Identify the role of medical nutrition therapy to support the management of obesity.
  • Develop an effective management strategy for NAFLD that considers potential risks and benefits of therapeutic options.
  • Summarize the role of Semaglutide in reducing CV risk
  • Explore new and future treatments for the management of obesity

Planning Committee

  • Milan Gupta, MD, FRCPC, FCCS, FACC, FAHA
  • Robert A. Hegele, MD, FRCPC, FACP, FAHA, FCAHS
  • Christine Palmay, MD, CCFP
  • Anil Maheshwari, MD, CCFP, DABOM, DABFM
  • Laura Reardon, MD, CCFP, ABOM Diplomate


  • Andrew Ha, MD, MSc, FRCPC
  • Tara Sedlak, MD, FRCPC, MBA
  • Kim Connelly, MD, PhD, MBBS, FSCMR, FCCS
  • Jordan Weinstein, MD, FRCPC
  • Stephanie Poon, MD, MSc, FRCPC
  • Robert Hegele, MD, FRCPC, Cert Endo, FACP
  • Michelle O'Donoghue, MD, MPH
  • Jennifer Brown, MSc., RD, CBE
  • Magnus McLeod, MD, FRCPC, DRCPSC
  • Megha Poddar, MD, FRCPSC


Being a part of CCRN has benefits